Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Preventive measures in risk factor control, recommended for patients with ischaemic heart disease, are reviewed, according to the European Guidelines. They require multidisciplinary intervention to succeed in lifestyle changes, as well pharmacological optimization.
The ESC Prevention of Cardiovascular Disease programme is supported by AMGEN, AstraZeneca, Ferrer for good, and Sanofi and Regeneron in the form of educational grants.
Our mission: To reduce the burden of cardiovascular disease.